Page last updated: 2024-11-02

phenylbutazone and Dyskinesia, Drug-Induced

phenylbutazone has been researched along with Dyskinesia, Drug-Induced in 1 studies

Phenylbutazone: A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS.
phenylbutazone : A member of the class of pyrazolidines that is 1,2-diphenylpyrazolidine-3,5-dione carrying a butyl group at the 4-position.

Dyskinesia, Drug-Induced: Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Venning, GR1

Other Studies

1 other study available for phenylbutazone and Dyskinesia, Drug-Induced

ArticleYear
Identification of adverse reactions to new drugs. II (continued): How were 18 important adverse reactions discovered and with what delays?
    British medical journal (Clinical research ed.), 1983, Jan-29, Volume: 286, Issue:6362

    Topics: Anemia, Aplastic; Clindamycin; Drug and Narcotic Control; Drug-Related Side Effects and Adverse Reac

1983